欧盟法院称欧盟委员会编辑 Covid-19 疫苗交易细节是错误的 || European Commission wrong to redact Covid-19 vaccine deal details, EU court says
AI Summary:
---------------
欧盟普通法院周三表示,欧盟委员会没有让公众充分了解其在大流行病期间与制药公司达成的 Covid-19 疫苗采购协议的相关信息。
该决定是在欧洲议会投票前一天做出的,欧盟委员会主席乌苏拉-冯德莱恩正在欧洲议会寻求连任。
在欧盟委员会拒绝允许他们完全查阅欧盟执行机构与制造商签订的 Covid-19 疫苗合同后,一群欧盟立法者采取了法律行动。
大流行病揭示了欧盟与大型制药集团之间疫苗谈判的透明度问题。成员国授权欧盟委员会在大流行期间组织联合采购疫苗,并领导与制造商的谈判。
据法院称,代表所有 27 个成员国采购疫苗使该集团能够迅速筹集到 27 亿欧元(29.5 亿美元),订购超过 10 亿剂疫苗。
2021 年,一些欧洲议会成员要求获得协议的全部细节,但欧盟委员会只同意提供部分合同和文件,并将其编辑后放在网上。欧盟委员会还拒绝透露它为获得的数十亿剂量支付了多少费用,理由是合同出于保密原因受到保护。
法院在一份声明中说,"委员会没有充分考虑所有相关情况,以正确权衡有关利益"。
两年前,欧盟监察专员在另一起案件中称,欧盟委员会对调阅其主席与辉瑞制药公司首席执行官之间有关 Covid-19 疫苗采购的短信请求处理不当,应为 "行政失当 "负责。
在《纽约时报》发表的一篇报道披露冯德莱恩和辉瑞公司首席执行官阿尔伯特-布尔拉曾就欧盟国家的疫苗采购交换短信和电话后,监察员艾米莉-奥莱利建议欧盟委员会 "更广泛地搜索 "与此类采购有关的 "相关信息"。
一名记者随后要求委员会查阅这些短信和其他文件,但行政部门没有提供任何短信,称没有保存这些短信的记录。委员会官员辩称,短信是短暂的,不包含重要信息,没有理由将其纳入文件管理系统。
法新社、路透社的补充报道
---------------
The European Commission did not allow the public enough access to information about Covid-19 vaccine purchase agreements it secured with pharmaceutical companies during the pandemic, the EU general court said Wednesday.
The decision came a day ahead of a vote at the European Parliament, at which European Commission President Ursula von der Leyen is seeking re-election.
A group of EU lawmakers had taken legal action after the Commission refused to grant them complete access to Covid-19 vaccine contracts secured between the EU’s executive arm and manufacturers.
The pandemic shed light on the issue of transparency surrounding the negotiations for vaccines between the EU and big pharmaceutical groups. The EU Commission was mandated by member countries to organise the joint procurement of vaccines during the pandemic and led negotiations with manufacturers.
According to the court, the procurement of vaccines on behalf of all 27 member states allowed the bloc to quickly gather 2.7 billion euros (US$2.95 billion) to place an order for more than a billion doses of vaccines.
In 2021, some members of the European Parliament asked for the full details of the agreements, but the Commission only agreed to provide partial access to certain contracts and documents, which were placed online in redacted versions. It also refused to say how much it paid for the billions of doses it secured, arguing that contracts were protected for confidentiality reasons.
In a statement, the court said that “the Commission did not take sufficient account of all the relevant circumstances in order to weigh up correctly the interests at issue.”
Two years ago, the EU’s ombudsman said in a separate case that the Commission was responsible for “maladministration” for mishandling a request for access to text messages between its president and the CEO of pharmaceutical company Pfizer regarding Covid-19 vaccine purchases.
Ombudsman Emily O’Reilly recommended that the European Commission “do a more extensive search for the relevant messages” relating to such purchases after a story published by The New York Times revealed that von der Leyen and Pfizer CEO Albert Bourla had exchanged text messages and calls about vaccine procurements for EU countries.
A journalist then asked the Commission for access to the text messages and other documents, but the executive branch did not provide any texts, saying no record of such messages had been kept. Commission officials had argued that text messages are ephemeral and don’t contain important information to justify their inclusion in a document management system.
Additional reporting by Agence France-Presse, Reuters
via News - South China Morning Post (author: Associated Press)
AI Summary:
---------------
欧盟普通法院周三表示,欧盟委员会没有让公众充分了解其在大流行病期间与制药公司达成的 Covid-19 疫苗采购协议的相关信息。
该决定是在欧洲议会投票前一天做出的,欧盟委员会主席乌苏拉-冯德莱恩正在欧洲议会寻求连任。
在欧盟委员会拒绝允许他们完全查阅欧盟执行机构与制造商签订的 Covid-19 疫苗合同后,一群欧盟立法者采取了法律行动。
大流行病揭示了欧盟与大型制药集团之间疫苗谈判的透明度问题。成员国授权欧盟委员会在大流行期间组织联合采购疫苗,并领导与制造商的谈判。
据法院称,代表所有 27 个成员国采购疫苗使该集团能够迅速筹集到 27 亿欧元(29.5 亿美元),订购超过 10 亿剂疫苗。
2021 年,一些欧洲议会成员要求获得协议的全部细节,但欧盟委员会只同意提供部分合同和文件,并将其编辑后放在网上。欧盟委员会还拒绝透露它为获得的数十亿剂量支付了多少费用,理由是合同出于保密原因受到保护。
法院在一份声明中说,"委员会没有充分考虑所有相关情况,以正确权衡有关利益"。
两年前,欧盟监察专员在另一起案件中称,欧盟委员会对调阅其主席与辉瑞制药公司首席执行官之间有关 Covid-19 疫苗采购的短信请求处理不当,应为 "行政失当 "负责。
在《纽约时报》发表的一篇报道披露冯德莱恩和辉瑞公司首席执行官阿尔伯特-布尔拉曾就欧盟国家的疫苗采购交换短信和电话后,监察员艾米莉-奥莱利建议欧盟委员会 "更广泛地搜索 "与此类采购有关的 "相关信息"。
一名记者随后要求委员会查阅这些短信和其他文件,但行政部门没有提供任何短信,称没有保存这些短信的记录。委员会官员辩称,短信是短暂的,不包含重要信息,没有理由将其纳入文件管理系统。
法新社、路透社的补充报道
---------------
The European Commission did not allow the public enough access to information about Covid-19 vaccine purchase agreements it secured with pharmaceutical companies during the pandemic, the EU general court said Wednesday.
The decision came a day ahead of a vote at the European Parliament, at which European Commission President Ursula von der Leyen is seeking re-election.
A group of EU lawmakers had taken legal action after the Commission refused to grant them complete access to Covid-19 vaccine contracts secured between the EU’s executive arm and manufacturers.
The pandemic shed light on the issue of transparency surrounding the negotiations for vaccines between the EU and big pharmaceutical groups. The EU Commission was mandated by member countries to organise the joint procurement of vaccines during the pandemic and led negotiations with manufacturers.
According to the court, the procurement of vaccines on behalf of all 27 member states allowed the bloc to quickly gather 2.7 billion euros (US$2.95 billion) to place an order for more than a billion doses of vaccines.
In 2021, some members of the European Parliament asked for the full details of the agreements, but the Commission only agreed to provide partial access to certain contracts and documents, which were placed online in redacted versions. It also refused to say how much it paid for the billions of doses it secured, arguing that contracts were protected for confidentiality reasons.
In a statement, the court said that “the Commission did not take sufficient account of all the relevant circumstances in order to weigh up correctly the interests at issue.”
Two years ago, the EU’s ombudsman said in a separate case that the Commission was responsible for “maladministration” for mishandling a request for access to text messages between its president and the CEO of pharmaceutical company Pfizer regarding Covid-19 vaccine purchases.
Ombudsman Emily O’Reilly recommended that the European Commission “do a more extensive search for the relevant messages” relating to such purchases after a story published by The New York Times revealed that von der Leyen and Pfizer CEO Albert Bourla had exchanged text messages and calls about vaccine procurements for EU countries.
A journalist then asked the Commission for access to the text messages and other documents, but the executive branch did not provide any texts, saying no record of such messages had been kept. Commission officials had argued that text messages are ephemeral and don’t contain important information to justify their inclusion in a document management system.
Additional reporting by Agence France-Presse, Reuters
via News - South China Morning Post (author: Associated Press)